Valuation: Novartis AG

Market Cap 287B 251B 232B 216B 407B 27,115B 415B 2,779B 1,079B 13,380B 1,077B 1,053B 46,613B P/E 2026 *
21.8x
P/E 2027 * 18.5x
Enterprise Value 319B 279B 258B 240B 453B 30,161B 461B 3,092B 1,200B 14,884B 1,198B 1,172B 51,851B EV / Sales 2026 *
5.61x
EV / Sales 2027 * 5.22x
Free-Float
91.66%
Yield 2026 *
2.82%
Yield 2027 * 2.9%
1 day-0.46%
1 week+0.53%
Current month-1.25%
1 month+9.75%
3 months+1.71%
6 months+15.21%
Current year+14.05%
1 week 123.1
Extreme 123.1
127.94
1 month 111.48
Extreme 111.48
127.94
Current year 107.68
Extreme 107.68
131
1 year 91.2
Extreme 91.2
131
3 years 81.1
Extreme 81.1
131
5 years 72.84
Extreme 72.84
131
10 years 65.09
Extreme 65.09
131
Manager TitleAgeSince
Chief Executive Officer 50 2018-01-31
Director of Finance/CFO - 2026-03-15
Chief Tech/Sci/R&D Officer 64 2022-05-15
Director TitleAgeSince
Director/Board Member 68 2014-12-31
Director/Board Member 69 2015-12-31
Director/Board Member 61 2015-12-31
Date Insider Type Main position Quantity % Market Cap.
May. 17Sell -5,200 0.0003%
May. 03Sell 6,800 0.0003%
Feb. 16Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-1.25%+0.53%+27.68%+41.18% 287B
-0.62%+6.13%+52.82%+156.97% 1,070B
-0.67%+4.43%+61.42%+54.07% 611B
-0.89%+5.79%+30.79%+84.05% 445B
-3.05%+4.18%+31.11%+23.88% 329B
-1.55%-0.20%+33.46%+33.82% 290B
+2.99%+4.00%-26.09%-40.14% 213B
-0.38%+2.03%+23.42%+59.35% 195B
-0.17%+0.89%+13.02%+64.61% 157B
-0.69%-0.71%-4.67%-34.87% 137B
Average -0.55%+4.26%+24.30%+44.29% 373.35B
Weighted average by Cap. -0.71%+6.32%+36.43%+73.98%

Financials

2026 *2027 *
Net sales 56.91B 49.81B 45.98B 42.89B 80.82B 5,381B 82.26B 552B 214B 2,655B 214B 209B 9,250B 60.4B 52.86B 48.8B 45.52B 85.77B 5,710B 87.3B 585B 227B 2,818B 227B 222B 9,817B
Net income 14.15B 12.38B 11.43B 10.66B 20.09B 1,338B 20.45B 137B 53.23B 660B 53.15B 51.96B 2,300B 15.73B 13.77B 12.71B 11.86B 22.34B 1,487B 22.74B 152B 59.19B 734B 59.1B 57.78B 2,557B
Net Debt 32.22B 28.2B 26.04B 24.29B 45.76B 3,047B 46.58B 312B 121B 1,503B 121B 118B 5,238B 28.73B 25.15B 23.22B 21.66B 40.8B 2,717B 41.53B 278B 108B 1,341B 108B 106B 4,670B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
26-07-01 CHF 125.00 -1.25% 2,793,087
26-06-30 CHF 126.58 +0.30% 3,123,994
26-06-29 CHF 126.20 -0.06% 2,366,228
26-06-26 CHF 126.28 +0.22% 3,716,090
26-06-25 CHF 126.00 +1.34% 2,913,400
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
156.66USD
Average target price
154.11USD
Spread / Average Target
-1.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock